LEMAITRE VASCULAR, INC. Marketable Securities, Gain (Loss)
LEMAITRE VASCULAR, INC. (LMAT) reported Marketable Securities, Gain (Loss) of -$34.00 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2012-03-27.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2012-03-27
- LEMAITRE VASCULAR, INC. marketable securities, gain (loss) for fiscal 2009 was -$34.00K.
| Period end | Marketable Securities, Gain (Loss) 12 month |
|---|---|
| 2009-12-31 | -$34.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |